News Release Detail
Mylan Names Patrick J. Gallagher, Vice President, Business Development
Mr. Gallagher will focus his attention on identifying company and/or product acquisitions, partnerships, licensing activities and other strategic opportunities.
Mr. Gallagher joins Mylan from Bristol-Myers Squibb where he served as Director, External Business Development since 1998. Prior to joining Bristol-Myers in 1996, Mr. Gallagher served in a variety of senior level business development positions at Ortho-McNeil Pharmaceutical Corporation.
Robert J. Coury, Vice Chairman and Chief Executive Officer of Mylan stated, "Mylan is fortunate to be able to attract a seasoned professional of Patrick's caliber. The scope and depth of his business development experience in the pharmaceutical arena makes him a valuable addition to the Mylan team."
Mr. Gallagher received a BS in Business Administration from LaSalle University and earned his MBA from the Wharton School of the University of Pennsylvania.
Mylan Laboratories Inc. is a leading pharmaceutical company that develops, manufactures and markets generic and proprietary prescription pharmaceutical products. The company markets an extensive line of generic products through three business units, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories, Inc. and branded products through its Bertek Pharmaceuticals Inc. subsidiary. For more information, visit www.mylan.com
CONTACT: Mylan Laboratories Inc.
Patricia Sunseri, 412/232-0100
URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2002 Business Wire. All rights reserved.